Recurrence · people requiring intervention for short saphenous vein varices
Endovenous laser ablation showed no clear difference in clinical evidence of recurrence after 1 year compared with conventional surgery (low certainty).
1 finding from 1 review
Reintervention (due to technical failure) · people requiring intervention for short saphenous vein varices
1 finding from 1 review
Disease‐specific quality of life · people requiring intervention for short saphenous vein varices
2 findings from 1 review
Complications at 6 weeks · people requiring intervention for short saphenous vein varices
1 finding from 1 review
FEV1 % predicted: relative change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Mortality at end of · patients with chronic obstructive pulmonary disease
Vapour ablation showed no clear difference in mortality at end of compared with control (low certainty).
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Meters at end of · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Vapour ablation showed no clear difference in adverse events at end of compared with control (moderate certainty).
1 finding from 1 review
Cost‐effectiveness · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether transarterial embolisation plus radiofrequency ablation changes mortality at maximal compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Cancer‐related mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events (number of participants) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether transarterial embolisation plus radiofrequency ablation changes serious adverse events (number of participants) compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Serious adverse events (number of events) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
1 finding from 1 review
Health‐related quality of life · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Effectiveness Proportion of women with perception of improvement of bleeding symptoms · heavy menstrual bleeding
Endometrial resection/ablation may leads to lower effectiveness Proportion of women with perception of improvement of… compared with unspecified (or at surgeon's discretion) route of hysterectomy (low certainty).
1 finding from 1 review
Quality of life SF‐36 at 2 years – general health perception · heavy menstrual bleeding
1 finding from 1 review
Proportion with improvement in general health · heavy menstrual bleeding
Endometrial resection/ablation may leads to lower proportion with improvement in general health compared with unspecified (or at surgeon's discretion) route of hysterectomy (low certainty).
1 finding from 1 review
Requirement for further surgery for treatment failure · heavy menstrual bleeding
1 finding from 1 review